Studying glucagon-like peptide-1 (GLP-1) induced vasodilatory effects on extra - and intracerebral arteries and headache in healthy volunteers and migraine patients without aura.
The purpose of this study is to examine the association between vasodilation and intensity of headache triggered by glucagon-like peptide 1 (GLP-1) in healthy volunteers and migraine patients without aura.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Enrollment
43
Receive intravenous infusion of GLP-1. The dosage will be determined after a dose finding pilot study.
Receive intravenous infusion saline
Dansk Hovedpinecenter
Glostrup Municipality, Denmark
RECRUITINGVasodilation
Difference in circumference (in millimeter) of intra - and extracranial blood vessels before and after GLP-1 or placebo infusion, measured by transcranial doppler and ultrasound (Derma scan) at 10 specific time points (-10, 10, 20, 30, 40, 50, 60, 80, 100, and 120 minutes)
Time frame: 120 minutes
Headache intensity
Headache intensity will be measured using Numerical rating scale (NRS) from ( 0 to 10 )
Time frame: 12 hours
blood pressure
Blood pressure (systolic and diastolic) in mmhg will be measured every 10 minutes
Time frame: 120 minutes
Facial skin perfusion
Non-invasive measuring of facial skin perfusion by laser speckle contrast imager.
Time frame: 120 minutes
Heart rate
heart rate will be measured every 10 minutes
Time frame: 120 minutes
Plasma glucose
Plasma glucose will be measured using (mmol/L) a ABL Radiometer, Denmark Blood-gas analyser
Time frame: 120 minutes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.